Skip to content
healthcare.dev

adenosine

NDC 25021-301, adenosine, injection, from Sagent Pharmaceuticals.

Product NDC
25021-301
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077283
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADENOSINE3 mg/mL

Pharmacologic classes

Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]

Package NDCNDC-11Package
25021-301-672502103016710 SYRINGE in 1 CARTON (25021-301-67) / 2 mL in 1 SYRINGE
25021-301-682502103016810 SYRINGE in 1 CARTON (25021-301-68) / 4 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5a55b45d-9cee-4c0c-9e44-021dbf70a018
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-301

Use it

Look up 25021-301 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-301 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.